Literature DB >> 27458300

Recommendations for Premature Ovarian Insufficiency Surveillance for Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Report From the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration With the PanCareSurFup Consortium.

Wendy van Dorp1, Renée L Mulder1, Leontien C M Kremer1, Melissa M Hudson1, Marry M van den Heuvel-Eibrink1, Marleen H van den Berg1, Jennifer M Levine1, Eline van Dulmen-den Broeder1, Natascia di Iorgi1, Assunta Albanese1, Saro H Armenian1, Smita Bhatia1, Louis S Constine1, Andreas Corrias1, Rebecca Deans1, Uta Dirksen1, Clarisa R Gracia1, Lars Hjorth1, Leah Kroon1, Cornelis B Lambalk1, Wendy Landier1, Gill Levitt1, Alison Leiper1, Lillian Meacham1, Alesandro Mussa1, Sebastian J Neggers1, Kevin C Oeffinger1, Alberto Revelli1, Hanneke M van Santen1, Roderick Skinner1, Andrew Toogood1, William H Wallace1, Riccardo Haupt1.   

Abstract

PURPOSE: Female survivors of childhood, adolescent, and young adult (CAYA) cancer who were treated with alkylating agents and/or radiation, with potential exposure of the ovaries, have an increased risk of premature ovarian insufficiency (POI). Clinical practice guidelines can facilitate these survivors' access to optimal treatment of late effects that may improve health and quality of survival; however, surveillance recommendations vary among the existing long-term follow-up guidelines, which impedes the implementation of screening. PATIENTS AND METHODS: The present guideline was developed by using an evidence-based approach and summarizes harmonized POI surveillance recommendations for female survivors of CAYA cancer who were diagnosed at age < 25 years. The recommendations were formulated by an international multidisciplinary panel and graded according to the strength of the evidence and the potential benefit gained from early detection and intervention. The harmonized POI surveillance recommendations were developed by using a transparent process and are intended to facilitate care for survivors of CAYA cancer. RESULTS AND
CONCLUSION: The harmonized set of POI surveillance recommendations is intended to be scientifically rigorous, to positively influence health outcomes, and to facilitate the care for female survivors of CAYA cancer.
© 2016 by American Society of Clinical Oncology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27458300      PMCID: PMC5569686          DOI: 10.1200/JCO.2015.64.3288

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  70 in total

Review 1.  American College of Cardiology/American Heart Association clinical practice guidelines: Part I: where do they come from?

Authors:  Raymond J Gibbons; Sidney Smith; Elliott Antman
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

2.  Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound.

Authors:  L E Bath; W H B Wallace; M P Shaw; C Fitzpatrick; R A Anderson
Journal:  Hum Reprod       Date:  2003-11       Impact factor: 6.918

Review 3.  Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults.

Authors:  Richard A Anderson; Rod T Mitchell; Thomas W Kelsey; Norah Spears; Evelyn E Telfer; W Hamish B Wallace
Journal:  Lancet Diabetes Endocrinol       Date:  2015-04-12       Impact factor: 32.069

4.  Medical assessment of adverse health outcomes in long-term survivors of childhood cancer.

Authors:  Maud M Geenen; Mathilde C Cardous-Ubbink; Leontien C M Kremer; Cor van den Bos; Helena J H van der Pal; Richard C Heinen; Monique W M Jaspers; Caro C E Koning; Foppe Oldenburger; Nelia E Langeveld; Augustinus A M Hart; Piet J M Bakker; Huib N Caron; Flora E van Leeuwen
Journal:  JAMA       Date:  2007-06-27       Impact factor: 56.272

5.  Correlation of ovarian reserve tests with histologically determined primordial follicle number.

Authors:  Karl R Hansen; George M Hodnett; Nicholas Knowlton; LaTasha B Craig
Journal:  Fertil Steril       Date:  2010-06-01       Impact factor: 7.329

6.  Survival of European children and young adults with cancer diagnosed 1995-2002.

Authors:  Gemma Gatta; Giulia Zigon; Riccardo Capocaccia; Jan Willem Coebergh; Emmanuel Desandes; Peter Kaatsch; Guido Pastore; Rafael Peris-Bonet; Charles A Stiller
Journal:  Eur J Cancer       Date:  2009-02-21       Impact factor: 9.162

7.  Ovarian failure in long-term survivors of childhood malignancy.

Authors:  R J Stillman; J S Schinfeld; I Schiff; R D Gelber; J Greenberger; M Larson; N Jaffe; F P Li
Journal:  Am J Obstet Gynecol       Date:  1981-01       Impact factor: 8.661

8.  Anti-müllerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies.

Authors:  S Lie Fong; P J Lugtenburg; I Schipper; A P N Themmen; F H de Jong; P Sonneveld; J S E Laven
Journal:  Hum Reprod       Date:  2008-01-23       Impact factor: 6.918

9.  Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice.

Authors:  Marlies E Kevenaar; Mohamed F Meerasahib; Piet Kramer; Brigitte M N van de Lang-Born; Frank H de Jong; Nigel P Groome; Axel P N Themmen; Jenny A Visser
Journal:  Endocrinology       Date:  2006-03-23       Impact factor: 4.736

10.  Genome-wide association studies identify loci associated with age at menarche and age at natural menopause.

Authors:  Chunyan He; Peter Kraft; Constance Chen; Julie E Buring; Guillaume Paré; Susan E Hankinson; Stephen J Chanock; Paul M Ridker; David J Hunter; Daniel I Chasman
Journal:  Nat Genet       Date:  2009-05-17       Impact factor: 38.330

View more
  35 in total

1.  Fertility preservation issues in pediatric hematopoietic stem cell transplantation: practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group.

Authors:  A Balduzzi; J-H Dalle; K Jahnukainen; M von Wolff; G Lucchini; M Ifversen; K T Macklon; C Poirot; T Diesch; A Jarisch; D Bresters; I Yaniv; B Gibson; A M Willasch; R Fadini; L Ferrari; A Lawitschka; A Ahler; N Sänger; S Corbacioglu; M Ansari; R Moffat; A Dalissier; E Beohou; P Sedlacek; A Lankester; C D De Heredia Rubio; K Vettenranta; J Wachowiak; A Yesilipek; E Trigoso; T Klingebiel; C Peters; P Bader
Journal:  Bone Marrow Transplant       Date:  2017-07-24       Impact factor: 5.483

2.  Global oncofertility index-data gap slows progress.

Authors:  Saskia F de Roo; Alexandra S Rashedi; Catharina C M Beerendonk; Antoinette Anazodo; Anne Marie de Man; Willianne L D M Nelen; Teresa K Woodruff
Journal:  Biol Reprod       Date:  2017-06-01       Impact factor: 4.285

Review 3.  Surveillance for Late Effects in Childhood Cancer Survivors.

Authors:  Wendy Landier; Roderick Skinner; W Hamish Wallace; Lars Hjorth; Renée L Mulder; F Lennie Wong; Yutaka Yasui; Nickhill Bhakta; Louis S Constine; Smita Bhatia; Leontien C Kremer; Melissa M Hudson
Journal:  J Clin Oncol       Date:  2018-06-06       Impact factor: 44.544

4.  Updated Breast Cancer Surveillance Recommendations for Female Survivors of Childhood, Adolescent, and Young Adult Cancer From the International Guideline Harmonization Group.

Authors:  Renée L Mulder; Melissa M Hudson; Smita Bhatia; Wendy Landier; Gill Levitt; Louis S Constine; W Hamish Wallace; Flora E van Leeuwen; Cécile M Ronckers; Tara O Henderson; Chaya S Moskowitz; Danielle N Friedman; Andrea K Ng; Helen C Jenkinson; Charlotte Demoor-Goldschmidt; Roderick Skinner; Leontien C M Kremer; Kevin C Oeffinger
Journal:  J Clin Oncol       Date:  2020-09-29       Impact factor: 44.544

5.  Fertility-Related Perceptions and Impact on Romantic Relationships Among Adult Survivors of Childhood Cancer.

Authors:  Vicky Lehmann; Leena Nahata; Amanda C Ferrante; Jennifer A Hansen-Moore; Nicholas D Yeager; James L Klosky; Cynthia A Gerhardt
Journal:  J Adolesc Young Adult Oncol       Date:  2018-02-21       Impact factor: 2.223

6.  Premature Ovarian Insufficiency in Childhood Cancer Survivors: A Report From the St. Jude Lifetime Cohort.

Authors:  Wassim Chemaitilly; Zhenghong Li; Matthew J Krasin; Russell J Brooke; Carmen L Wilson; Daniel M Green; James L Klosky; Nicole Barnes; Karen L Clark; Jonathan B Farr; Israel Fernandez-Pineda; Michael W Bishop; Monika Metzger; Ching-Hon Pui; Sue C Kaste; Kirsten K Ness; Deo Kumar Srivastava; Leslie L Robison; Melissa M Hudson; Yutaka Yasui; Charles A Sklar
Journal:  J Clin Endocrinol Metab       Date:  2017-07-01       Impact factor: 5.958

Review 7.  Development of a Pediatric Fertility Preservation Program: A Report From the Pediatric Initiative Network of the Oncofertility Consortium.

Authors:  Molly B Moravek; Leslie C Appiah; Antoinette Anazodo; Karen C Burns; Veronica Gomez-Lobo; Holly R Hoefgen; Olivia Jaworek Frias; Monica M Laronda; Jennifer Levine; Lillian R Meacham; Mary Ellen Pavone; Gwendolyn P Quinn; Erin E Rowell; Andrew C Strine; Teresa K Woodruff; Leena Nahata
Journal:  J Adolesc Health       Date:  2019-01-14       Impact factor: 5.012

Review 8.  Oncofertility: Meeting the Fertility Goals of Adolescents and Young Adults With Cancer.

Authors:  H Irene Su; Yuton Tony Lee; Ronald Barr
Journal:  Cancer J       Date:  2018 Nov/Dec       Impact factor: 3.360

9.  2019 Pediatric Initiative Network: Progress, Proceedings, and Plans.

Authors:  Leena Nahata; Veronica Gomez-Lobo; Lillian Meacham; Leslie Appiah; Krista Childress; Holly Hoefgen; Maggie Dwiggins; Stacy Whiteside; Kari Bjornard; Julie Rios; Antoinette Anazodo; Courtney Finlayson; Olivia Frias; Teresa Woodruff; Molly Moravek
Journal:  J Adolesc Young Adult Oncol       Date:  2020-05-27       Impact factor: 2.223

Review 10.  Hypogonadism in Children with a Previous History of Cancer: Endocrine Management and Follow-Up.

Authors:  Hanneke M van Santen; Marry M van den Heuvel-Eibrink; Marianne D van de Wetering; W Hamish Wallace
Journal:  Horm Res Paediatr       Date:  2019-01-31       Impact factor: 2.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.